Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 2,400 shares at $72.45 ($174K) on 2017-06-01, disclosed to the SEC on 2017-06-05.
Open-market sale of $174k KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |